Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01325142 · ClinicalTrials.gov registry record
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
A clinical trial of Osteonecrosis and Metastases, sponsored by University of Michigan.
- Completed
- Registry status
- 271
- Enrollment target
- 1
- Study location
NCT01325142 is a study of Osteonecrosis and Metastases that has completed, run by University of Michigan. The registered enrollment target is 271 participants, below the 2,884-participant average among 7 other Osteonecrosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01325142, a study of Osteonecrosis and Metastases, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 271 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to identify risk factors associated with the development of a jaw condition seen in patients with cancer treated with certain medications.
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01325142
The ClinicalTrials.gov registry entry for NCT01325142 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 271 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,884-participant average among 7 other Osteonecrosis trials with a reported enrollment target (91% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Osteonecrosis appearing as the primary indexed condition, and to 0 interventions.
NCT01325142 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01325142 about?
NCT01325142 is a clinical study titled "Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer". This study seeks to identify risk factors associated with the development of a jaw condition seen in patients with cancer treated with certain medications.
What is the current status of trial NCT01325142?
This trial is currently completed. The enrollment target is 271 participants. The study started on 2010-08. Estimated completion is 2014-11.
What conditions does trial NCT01325142 study?
This clinical trial studies the following conditions: Osteonecrosis, Metastases, Bone Diseases, Bisphosphonate-Associated Osteonecrosis of the Jaw.
Who is sponsoring clinical trial NCT01325142?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01325142 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteonecrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
RECRUITING · Phase 2
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Exactech Shoulder Post Market Clinical Follow-up Study
RECRUITING
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
-
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
ACTIVE NOT RECRUITING
-
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.